Mobeen Mazhar, M.D. – FDA Inspection, Apr 28, 2022

Record Details

This FDA Inspection record concerns Mobeen Mazhar, M.D., with an inspection on April 28, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Mobeen Mazhar, M.D.
Inspection Date: April 28, 2022
Product Type: Drugs
Office: Center for Drug Evaluation and Research

View Company Profile

ID · 7b49aa44-890e-479a-9780-009b03c6b117

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1168224
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Enforcement: Warning Letter

FDA Citations

21 CFR 312.60FD-1572, protocol compliance
21 CFR 312.64(b)Safety reports
21 CFR 312.62(a)Accountability records

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mobeen Mazhar, M.D.

FDA Inspection

Mobeen Mazhar, M.D.April 28, 2022